Actio Biosciences launches trial of precision medicine for rare childhood epilepsy
Actio Biosciences has launched a Phase 1b/2 clinical trial of ABS-1230, an investigational precision medicine for KCNT1-related epilepsy. KCNT1-related epilepsy is a…
Children with rare, debilitating brain diseases suffer from mutations in a little-known protein complex
Thousands of times per year, a family’s moment of joy turns to unexpected grief. A seemingly healthy infant stops smiling or making…
Male sex hormones drive aggressive childhood brain tumour, study finds
Scientists have identified a key biological driver of one of the most lethal brain tumours in young children, in findings that could…
Study reveals early developmental gaps in twins compared to siblings
Twins often don’t pick up new skills quite as fast as single-born children in their early years, according to the findings of…
Struggling to identify emotions may increase vulnerability to TikTok addiction
No matter where we turn on social media, short videos are everywhere. Repeated exposure to this brief, information-dense, and rewarding content stimulates…